Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress - König, Wolfgang; Brenner, Hermann (Arteriosclerosis, thrombosis, and vascular biology, 2006)